跳至主要内容
临床试验/NCT06410885
NCT06410885尚未招募不适用

Assessment of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device in Asymptomatic Patients

Rhaeos, Inc.1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
Rhaeos, Inc.
入组人数
60
试验地点
1
主要终点
Study device negative predictive value (NPV)

研究概览

简要总结

This study evaluates the performance of the study device, FlowSense®, a sensor for non-invasively assessing cerebrospinal fluid (CSF) shunt flow. Subjects with an existing implanted ventricular CSF shunt will be evaluated with the study device in an outpatient setting to determine the negative predictive value (NPV; Part 1, blinded) and explore changes in surveillance imaging, health resource utilization, and visit duration during routine follow-up visits (Part 2, unblinded).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
2 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Existing ventricular cerebrospinal fluid shunt
  • •Age ≥ 2 years old
  • •Region of intact skin overlying an unambiguously identifiable palpable chronically indwelling ventricular shunt that crosses the clavicle; region of skin is appropriate in size for application of the study device
  • •Capable of providing informed consent or have a legal guardian, health care agent, or surrogate decision-maker able to provide informed consent
  • •Standard of care outpatient visit with neurosurgeon assessment of having "no clinical concern for shunt malfunction"

排除标准

  • •Subject not scheduled to receive outpatient standard of care imaging (CT, MRI, X-ray shunt series) as part of the clinic visit
  • •Presence of more than one distal shunt catheter in the study device measurement region
  • •Presence of an interfering open wound or edema in the study device measurement region
  • •Subject-reported history of adverse skin reactions to silicone adhesives
  • •Participation in the study will interfere with, or be detrimental to, the administration of optimal health care to the subject
  • •Subject not available for seven-day follow-up

研究组 & 干预措施

Observational, part 1 (blinded)

Experimental

干预措施: Thermal Anisotropy Measurement Device (Device)

Diagnostic, part 2 (unblinded)

Experimental

干预措施: Thermal Anisotropy Measurement Device (Device)

结局指标

主要结局

Study device negative predictive value (NPV)

时间窗: Up to 7 days

The study device will produce either "flow confirmed" or "flow not confirmed" data in a blinded fashion. Ground truth will be established based on 7-day follow-up an intraoperative observations for any surgery performed per the standard of care.

次要结局

  • Study device sensitivity, specificity, diagnostic accuracy, and positive predictive value (PPV)(Up to 7 days)

研究者

发起方
Rhaeos, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验